Clinical Trials Coordinator / Research Coordinator

1. 1
   Complete GCP Training — The Baseline Requirement

   GCP (Good Clinical Practice) is the international ethical and scientific standard for designing, conducting, recording, and reporting clinical trials. ICH E6(R2) GCP guidelines are the foundational document. GCP certification: the NIH provides free online GCP training through its Clinical Research Training program (training.nih.gov). Collaborative Institutional Training Initiative (CITI Program) offers GCP modules widely required by institutional research programs ($100 individual or free through many universities). No clinical research role at any legitimate site operates without GCP training — it is the absolute baseline.

   GCP training — CITI Program or NIH free training
2. 2
   Understand FDA Regulations and ICH Guidelines

   Clinical trials in the U.S. operate under FDA oversight. Key regulations: 21 CFR Part 11 (electronic records), 21 CFR Part 50 (informed consent), 21 CFR Part 54 (financial disclosure), 21 CFR Parts 312 and 812 (IND and IDE regulations for drugs and devices). The IRB (Institutional Review Board) reviews and approves all research involving human subjects — coordinators submit amendments, continuing reviews, and adverse event reports to the IRB. Understanding the regulatory framework is what separates a coordinator from an administrative assistant.

   FDA 21 CFR regulations + IRB process fundamentals
3. 3
   Build Protocol Management and Data Collection Skills

   The coordinator's core daily work: protocol compliance (ensuring every patient visit, assessment, and procedure happens exactly as specified in the protocol), informed consent management (ensuring consent is properly obtained, documented, and re-consented when amendments occur), data entry into EDC systems (Electronic Data Capture — REDCap, Medidata Rave, Veeva Vault are common), source document management (maintaining the records that verify EDC data), and query resolution (responding to data clarification requests from sponsors or CROs). Attention to detail in data collection directly affects the quality of evidence used to approve or reject medical interventions.

   Protocol compliance + EDC data entry + source documentation
4. 4
   Earn CCRP or CCRC Certification

   CCRP (Certified Clinical Research Professional) from SOCRA requires 1 year of clinical research experience and passing the exam covering: ethical and participant protection, regulatory, scientific concepts, study management, communication, and data management. CCRC (Certified Clinical Research Coordinator) from ACRP (Association of Clinical Research Professionals) is the alternative credential. Both are recognized by sponsors, CROs, and academic medical centers as evidence of professional competency and commitment to the field. CCRP exam fee: approximately $325 for SOCRA members.

   CCRP (SOCRA) or CCRC (ACRP) certification
5. 5
   Advance to Senior Coordinator, CRA, or Research Manager

   Career paths: Senior Clinical Trials Coordinator ($72K–$88K) — manages more complex studies, mentors junior coordinators. Clinical Research Associate (CRA/Monitor, $75K–$105K) — works for sponsors or CROs monitoring study sites for compliance, typically requires travel. Clinical Research Manager ($85K–$110K) — oversees research programs at a site or sponsor. Project Manager at a CRO — manages multiple clinical studies simultaneously. Regulatory Affairs ($80K–$115K) — uses regulatory knowledge for drug/device approval strategy.

   CRA monitor role or research manager advancement

• 8:00 AMProtocol deviation report — a patient enrolled in a Phase III oncology trial missed a required 12-week assessment visit by 5 days — outside the ±3 day visit window. This is a protocol deviation. Complete the deviation report: document what occurred, why, and whether it affects safety or data integrity. Submit to the IRB and sponsor within 24 hours per the protocol requirement. Prepare the patient for the out-of-window visit today.
• 9:30 AMPatient visit — 10 AM visit for a Phase II subject at Week 8. Review the visit schedule: vitals, ECOG performance status assessment, blood draw (4 tubes per the lab manual), and QoL questionnaire. Complete the informed consent re-verification (required at each visit). Collect and process the blood samples per the protocol — ship the pharmacokinetic samples on dry ice to the central lab within 4 hours.
• 11:00 AMEDC data entry — enter last week's patient visit data into Medidata Rave. Three data queries from the sponsor's data manager: one vital sign value flagged as out of range (transcription error — correct from source), one date discrepancy, and one missing adverse event grade. Resolve all three queries and document the source of each correction.
• 12:00 PMLunch — 30 minutes.
• 1:00 PMMonitoring visit prep — the CRA (Clinical Research Associate) from the sponsor is visiting Friday for a routine monitoring visit. Pull all source documents for the 3 subjects being reviewed: consent forms, medical records, lab reports, and visit notes. Ensure the regulatory binder is current: all amendments filed, current IRB approval letter present, investigator delegation log signed.
• 3:00 PMNew enrollment screen — a potentially eligible patient referred from the oncology clinic. Review the inclusion/exclusion criteria against the patient's chart. One potential exclusion: prior anthracycline therapy — check the dose threshold in the protocol. The patient's cumulative dose is below the threshold — eligible to proceed. Schedule the screen visit for next week and initiate the consent process.
• 4:30 PMIRB continuing review submission — the annual continuing review for a Phase I study is due in 14 days. Complete the CIRS form: current enrollment (12 of 30), adverse events (2 Grade 1, 1 Grade 2 — all expected), protocol deviations (1, previously reported), and updated risk-benefit assessment. Submit through the electronic IRB system.

AI is entering clinical trials at multiple points — patient recruitment, protocol feasibility, EDC data monitoring, and regulatory document preparation. However, the human relationship with research participants, IRB navigation, site-level protocol oversight, and the judgment required for complex protocol decisions remain firmly human. The coordinator role is becoming more AI-assisted rather than AI-replaced.